MedTrace Logo

Endoscopic Retrograde Cholangiopancreatography(ERCP)-Related Discussion Through a Mobile Social App by a Group of Doctors

NCT02537301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-01-12

No results posted yet for this study

Summary

Group chat through the platform of mobile social networking provides an easily accessible, real-time and interactive channel for communication. With the help of mobile social app, a group of doctors with similar interests can share valuable cases, important papers and opinions through multiple media types (texts, images, and videos). It remains unknown what activities of Endoscopic Retrograde Cholangiopancreatography(ERCP) doctors on a group-chat platform are.

In the beginning of 2013, a chatting group on Wechat (the most popular mobile social app in China), focusing on ERCP, was created. All the doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases were invited to join in the platform. The contents in the chatting group were analyzed. The relationships between the chatting activities of ERCP doctors and the performance of ERCP (such as case volume, cannulation success rate and PEP etc.) were investigated.

Conditions

  • Healthy

Interventions

OTHER

joining in the platform

The activities (contents, chatting frequency etc.) of ERCP doctors on the chatting group were retrospectively extracted. The data related to the performance of ERCP (such as case volume, cannulation success rate and PEP etc.) by ERCP doctors were collected by a questionaire.

Sponsors & Collaborators

  • Air Force Military Medical University, China

    lead OTHER

Principal Investigators

  • Yanglin Pan · Xijing Hospital of Disgestive Diseases.The Fourth Military University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02537301 on ClinicalTrials.gov